Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. (Q34637395)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. |
scientific article |
Statements
Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin (English)
Takara L Stanley
Julian Falutz
Christian Marsolais
Josée Morin
Graziella Soulban
Hani Assaad
Ralph Turner
Steven K Grinspoon
10 April 2012
1 reference
1 reference
1 reference
1 reference
1 reference